Mountain View, CA, United States of America

Francisco Xavier Talamas

USPTO Granted Patents = 32 (Patent Applications = 7)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 17)

Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 135(Granted Patents)

Location History:

Mountain View, CA (US) (2001 - 2012)
Livingston, NJ (US) (2011 - 2018)

Company Filing History:

Hoffmann-la Roche Inc.

where one patent can have more than one assignee

Years Active: 2001-2018

Loading Chart...

32 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10023589 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2018-07-17),

2. 9708357 - 4'-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication (2017-07-18),

3. 9255110 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2016-02-09),

4. 8734777 - Heterocyclic antiviral compounds (2014-05-27),

5. 8487103 - Quinoline inhibitors of hepatitis C virus polymerase (2013-07-16),

6. 8329712 - Heterocyclic antiviral compounds (2012-12-11),

7. 8273773 - Heterocyclic antiviral compounds (2012-09-25),

8. 8232271 - Heterocyclic antiviral compounds (2012-07-31),

9. 8178547 - Heterocyclic antiviral compounds (2012-05-15),

10. 8168792 - Heterocyclic antiviral compounds (2012-05-01),

11. 8158803 - Heterocyclic antiviral compounds (2012-04-17),

12. 8158631 - Heterocyclic antiviral compounds (2012-04-17),

13. 8071797 - Heterocyclic antiviral compounds (2011-12-06),

14. 8067442 - Heterocyclic antiviral compounds (2011-11-29),

15. 8063072 - Heterocyclic antiviral compounds (2011-11-22),

Title: Francisco Xavier Talamas: A Pioneer in Pharmaceutical Innovations

Introduction: Francisco Xavier Talamas is a notable inventor based in Mountain View, California, with an impressive portfolio of 32 patents. His work primarily focuses on pharmaceutical advancements, playing a crucial role in developing novel compounds for various therapeutic applications.

Latest Patents: Among his latest innovations, Talamas has developed Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators, which are useful for treating IRAK-mediated conditions. These compounds, represented by specific formulas, showcase the potential of targeted therapies in modern medicine. Additionally, he has patented 4'-azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication. This invention emphasizes the use of 3'-fluoro, 4'-azido nucleoside phosphoramidate prodrug derivatives in combating Hepatitis C Virus, further demonstrating his contributions to the pharmaceutical field.

Career Highlights: Talamas has had a dynamic career, having worked with leading companies such as Roche Palo Alto LLC and Syntex (U.S.A.) Inc. His involvement in these organizations has facilitated the advancement of innovative solutions, impacting the pharmaceutical landscape positively.

Collaborations: Throughout his career, Talamas has collaborated with esteemed colleagues, including Sharada Shenvi Labadie and Jim W. Li. These partnerships have fostered a creative and intellectually stimulating environment, contributing to the successful development of his patented inventions.

Conclusion: Francisco Xavier Talamas is a remarkable inventor whose contributions to pharmaceutical innovations are significant. His patented work continues to influence the treatment of various diseases, showcasing the importance of collaboration and ingenuity in the field of medical research and development.

This text is generated by artificial intelligence and may not be accurate.